GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Tumor necrosis factor ligand superfamily member 15, membrane form
                                 Compound class: 
                                                            Endogenous peptide in human, mouse or rat
                                 
                                    
                                        Comment: TL1A occurs as both membrane‐bound and soluble forms. It principally functions as a negative modulator of epithelial cell proliferation. Inhibiting the TL1A/death receptor 3 (TNFRSF25) pathway has been proposed as mechanism to treat inflammatory bowel disease [1]. In addition, TL1A has been associated with tumourigenesis and progression of some gastrointestinal malignancies  [3,5,7], making it a target of interest for the development of novel anti-cancer drugs.
                                    
                                 
                                    Species: Human
                                 | 
| Selected 3D Structures | ||
| 
 | ||
| Post-translational Modification | |
| Predicted N-linked glycosylation of asparagine residues at positions 133 and 229; disulphide bond formation between cysteine residues at positions 162 and 202 | |